Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 2431, 435 6, 435375, 514 4, C07H 2104, C12Q 168, C12N 506, A61K 3170

Patent

active

058408754

ABSTRACT:
This invention is a method for treating diseases involving the mammalian kidney proximal tubule epithelium with naked antisense oligonucleotides and antisense compositions against the mRNA of mammalian kidney epithelial proteins.

REFERENCES:
H. Tenenhouse et al., The American Society for Clinical Investigation, Inc., 93, pp. 671-676 (1994).
U. Laemmli, Nature, 227, pp. 680-685 (1970).
C. Allain et al., Clinical Chemistry, 20:4, pp. 470-475 (1974).
H. Towbin et al., Proc. Natl. Acad. Sci. USA, 76:9, pp. 4350-4354 (1979).
R. Stoll et al., Biochem. J., 180, pp. 465-470 (1979).
J. Emtage et al., Proc. Natl. Acad. Sci. USA, 80, pp. 3671-3675 (1983).
M. Jaye et al., Nucleic Acids Research, 11:8, pp. 2325-2335 (1983).
R. Labow et al., Biochimica et Biophysica Acta, 749, pp. 32-41 (1983).
A. Ullrich et al., The EMBO Journal, 3:2, pp. 361-364, (1984).
C. Brown et al., Biochimica et Biophysica Acta, 769, pp. 471-478 (1984).
E. Rudd et al., Biochimica et Biophysica Acta, 918, pp. 106-114 (1987).
J. Han et al., Biochemistry, 26, pp. 1617-1625 (1987).
D. Fitzpatrick et al., Journal of Virology, 62:11, pp. 4239-4248 (1988).
N. Abouakil et al., Biochimica et Biophysica Acta, 961, pp. 299-308 (1988).
L. Yakubov et al., Proc. Natl. Acad. Sci. USA, 86, pp. 6454-6458 (1989).
E. Christensen et al., Seminars in Nephrology, 11:4, pp. 414-439 (1991).
S. Agrawal et al., Proc. Natl. Acad. Sci. USA, 88, pp. 7595-7599 (1991).
J. Leonetti et al., Proc. Natl. Acad. Sci. USA, 88, pp. 2702-2706 (1991).
M. Simons et al., Nature, 359, pp. 67-71 (1992).
M. Ratajczak et al., Proc. Natl. Acad. Sci. USA, 89, pp. 11823-11827 (1992).
W. Gao et al., Molecular Pharmacology, 43, pp. 45-50 (1993).
L. Neckers et al., Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9), pp. L1-L12 (1993).
C. Stein et al., Science, 261, pp. 1004-1012 (1993).
R. Morishita et al., Proc. Natl. Acad. Sci. USA, 90, pp. 8474-8478 (1993).
S. Magagnin et al., Proc. Natl. Acad. Sci. USA, 90, pp. 5979-5983 (1993).
P. Cossum et al., The Journal of Pharmacology and Experimental Therapeutics, 267:3, pp. 1181-1190 (1993).
A. Werner et al., The Journal of Biological Chemistry, 269:9, pp. 6637-6639 (1994).
J. Cohen, Advances in Pharmacology, 25, pp. 319-339 (1994).
N. Dean et al., Proc. Natl. Acad. Sci. USA, 91, pp. 11762-11766 (1994).
P. Zamecnik et al., Proc. Natl. Acad. Sci. USA, 91, pp. 3156-3160 (1994).
M. Custer et al., American Physiological Society, pp. F767-F774 (1994).
R. Wagner, Nature, 372, pp. 333-335 (1994).
Collins et al. "Molecular cloning, functional expression, tissue distribution, and in situ hybridization of the renal sodium phosphate (Na/Pi) transporter in the control and hypophosphatemic mouse" FASEB Journal 8: 862-868, Aug. 1994.
Gura "Antisense has growing pains" Science 270: 575-577, Oct. 1995.
Stull et al. "Antigene, ribozyme, and aptame nucleic acid drugs: Progress and prospects" Pharm. Res. 12: 465-481, Apr. 1995.
Uhlmann et al. "Antisense oligonucleotides: A new therapeutic principle" Chem. Rev. 90: 544-584, Jun. 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1703659

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.